GE Healthcare announced the first seven markets where Vizamyl (Flutemetamol F18 injection), a radioactive diagnostic agent approved by the U.S. Food and Drug Administration (FDA) will be available.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now